logo
Maryland better-prepared for another pandemic 5 years after COVID, experts say

Maryland better-prepared for another pandemic 5 years after COVID, experts say

Yahoo12-03-2025
BALTIMORE — Five years to the day after the World Health Organization declared COVID-19 a pandemic, local leaders in COVID-19-related health care say the virus has forever changed Maryland, the U.S. and the world — in some ways, they said, for the better.
The WHO declared the pandemic on Wednesday, March 11, 2020, when case numbers and the number of countries where the virus was appearing had spiked alarmingly in just two weeks. The next day, Gov. Larry Hogan announced that Maryland would close schools for two weeks, a period that stretched into 18 months of virtual learning for most. Soon, workplaces shut down, grocery stores limited their hours, and hand sanitizer and face masks became staples in many homes as researchers raced to develop a vaccine.
Ultimately, the pandemic killed 1.2 million people in the U.S., according to the Centers for Disease Control. Both the WHO and the U.S. ended their COVID-19 emergency declarations in 2023, with many doctors shifting to treating COVID like the flu: a virus for which outbreaks will continue to ebb and flow.
Maryland suffered 1.5 million cases; 18,352 died from the virus within the state's borders, state data says. One hundred and eight are currently hospitalized with COVID-19, according to the Maryland Department of Health. Seven are children.
The COVID-19 pandemic has had a lasting effect on the country and our state, several Maryland medical experts said, as the lessons learned have put communities in a better position in the event of another pandemic.
'From my standpoint, I do think we're better,' said Dr. Panagis Galiatsatos, co-founder and co-director of Johns Hopkins' Medicine for the Greater Good, a curriculum that works to improve medical messaging to communities across different cultures.
Galiatsatos, who is triple-board certified in internal medicine, intensive care and pulmonology, worked in the intensive care unit during the pandemic. He held the hand of well over 100 people as they died, he said, 'because their families would request they not pass away alone.'
While Galiatsatos was working in the ICU, he was also working to improve lines of communication with different neighborhoods and groups of people across the city with Medicine for the Greater Good. The organization connected with hundreds of religious and community leaders, strengthening medical messaging and learning how best to approach different communities to ensure they had access to concise, actionable information.
'If there's a silver lining of the pandemic,' Galiatsos said, 'if another public health crisis comes along we can streamline medical messaging as best we can and allow people to make decisions for themselves.'
The medical community 'needs to recognize how cultures take in information,' he said. 'If you infringe on it, that's how you create a lot of friction.'
This is a big shift from medical messaging at the start of the pandemic, which relied largely on scientists and doctors standing at podiums, Galiatsos said. In turn, many people across the U.S. turned to people they trusted to interpret the information for them, and the message didn't always land.
Dr. Laura Malone, the executive director of the Kennedy Krieger Institute, a research and treatment facility for children with special needs, agreed.
'The pandemic was such a shift in daily lives for Marylanders and people all across the United States,' Malone said. 'So much has changed in the past five years. Think about where we were and what we didn't know in March 2020.'
Too, Malone noted, the medical community has come a long way in learning how to identify and treat COVID-19, resulting in much better outcomes for most patients.
While history shows us that it is almost certain another pandemic will occur, Malone said, she added that the COVID-19 pandemic taught us a lot about how to navigate a highly infectious virus.
'Doctors are continuing to develop rapid advances in scientific innovations and clinical treatments,' Malone said. 'Since 2020, ideas like remote learning, hybrid working, telehealth meetings, and more have been integrated into our culture.
'Most of all, Maryland knows how to come together as a community and would certainly be able to do so again.'
However, not all outcomes are good for those infected with the virus — and not all the changes are positive.
Malone said since the pandemic began, her practice has seen a lot of children come in with debilitating fatigue and post-exertional malaise.
'These experiences have always existed, but they weren't nearly as common before the pandemic,' Malone said. 'We also are seeing a lot of children with new dizziness, brain fog, or cognitive difficulties after having COVID.'
Those who've had multiple COVID infections are also at greater risk of developing Long COVID — a chronic condition with varied symptoms — according to the CDC. Studies are now underway to learn about the condition and find ways to prevent it.
Harder to quantify are the effects of the lost time for many groups — including grandparents who were cut off from their grandchildren, and students from their classmates and friends — and the lost loved ones.
'Calling us doctors doesn't make us less human,' Galiatsos said of the difficulty of tending to his neighbors as the coronavirus took their lives.
Health care workers on the front lines like Galiatsos were hailed as heroes throughout the pandemic, and righfully so, suggested Chase Cook, a spokesperson for the Maryland Department of Health.
'We are proud of the work that thousands of health care officials, community health workers, case investigators and epidemiologists have done during the past five years to protect Marylanders,' he said. 'However, our work is not done when it comes to fighting COVID-19. We continue to encourage Maryland residents to talk to a health care provider or visit vaccines.gov to find an updated COVID-19 vaccine near them.'
---------
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

WHO and UNICEF to Launch Polio Vaccination Campaign in Afghanistan with PharmaJet® Tropis® ID Delivery System
WHO and UNICEF to Launch Polio Vaccination Campaign in Afghanistan with PharmaJet® Tropis® ID Delivery System

Yahoo

timean hour ago

  • Yahoo

WHO and UNICEF to Launch Polio Vaccination Campaign in Afghanistan with PharmaJet® Tropis® ID Delivery System

PharmaJet has been awarded a UNICEF tender to support WHO and GlobalPolio Eradication Initiative (GPEI) partners. This is the first large-scale implementation of intradermal (ID) polio immunization in Afghanistan. PharmaJet's award builds on the successful implementation of Tropis for ID delivery in polio vaccination campaigns in Pakistan, Nigeria, and Somalia. The use of Tropis ID in polio vaccination campaigns has improved vaccine coverage, decreased immunization program costs, and increased acceptability. GOLDEN, Colo., August 19, 2025--(BUSINESS WIRE)--PharmaJet®, a company that strives to improve the performance and outcomes of injectables with its enabling needle-free injection technology, today announced that the WHO prequalified Tropis ID delivery system will be used to support a polio eradication campaign sponsored by the National Emergency Operation Center (NEOC) Afghanistan, UNICEF, WHO, and other GPEI partners starting in August 2025. Focused on the Eastern region of Afghanistan, the campaign will deploy Tropis ID to administer 1.3 million fractional doses of inactivated polio vaccine (fIPV) to children ages 5 and under in parallel to oral polio vaccine (OPV) administration as part of a WHO-recommended strategy to boost humoral and mucosal immunity. Poliovirus has been eliminated in most parts of the world due to widespread vaccination campaigns, but it continues to circulate in Afghanistan and Pakistan. In 2024, wild poliovirus type 1 (WPV1) transmission rose significantly in Afghanistan. The use of Tropis ID enables site-to-site immunization, a strategy where vaccination services are offered at multiple, convenient locations. This approach is expected to help increase immunization coverage, particularly in high-risk areas. The Technical Advisory Group (TAG) on polio eradication endorsed the Afghanistan program's "Strategic Reset" to optimize site-to-site vaccination, while stressing the need for stronger leadership, community acceptance, and broad government engagement. Including Tropis ID fIPV in this immunization program supports Afghanistan's polio eradication goals to eliminate persistent virus lineages in the East, prevent new WPV1 cases in the East and South Regions, and prevent local transmission in other parts of the country.1 "We are pleased to be partnering with UNICEF, WHO, and NEOC Afghanistan in their continued efforts to eradicate polio," said Paul LaBarre, Senior Vice President Global Business Development, PharmaJet. "We aim to achieve high impact in the fight against poliovirus, including increased coverage, decreased costs, and high acceptability2 previously seen with Tropis ID delivered fIPV in Pakistan,2 Somalia,3 and Nigeria4." Refer to Instructions for Use to ensure safe injections and to review risks. About PharmaJet The PharmaJet mission is to improve the performance and outcomes of injectables with our enabling technology that better activates the immune system. We are committed to helping our partners realize their research and commercialization goals while making an impact on public health. PharmaJet Precision Delivery Systems™ can improve vaccine effectiveness, allow for a preferred patient and caregiver experience, and offer a proven path to commercialization. They are also safe, fast, and easy-to-use. The Stratis® System has U.S. FDA 510(k) marketing clearance, CE Mark, and WHO PQS certification to deliver medications and vaccines either intramuscularly or subcutaneously. The Tropis® System has CE Mark and WHO PQS certification for intradermal injections. They are both commercially available for global immunization programs. For more information or if you are interested in partnering with PharmaJet visit or contact PharmaJet here. Follow us on LinkedIn. About the NEOC Afghanistan NEOC Afghanistan is led by the Ministry of Public Health and the core members are WHO, UNICEF, BMGF, CDC, Rotary International, Core Group of Polio Project (CGPP), EPI manager and the National Polio Focal Point. About the Global Polio Eradication Initiative (GPEI)5 The Global Polio Eradication Initiative is a public-private partnership led by national governments with six partners – the World Health Organization (WHO), Rotary International, the US Centers for Disease Control and Prevention (CDC), the United Nations Children's Fund (UNICEF), Gates Foundation and Gavi, the vaccine alliance. Its goal is to eradicate polio worldwide. Launched in 1988 after the World Health Assembly passed a resolution to eradicate polio, the Global Polio Eradication Initiative, along with its partners, has helped countries to make huge progress in protecting the global population from this debilitating disease. As a result, the global incidence of polio has decreased by 99.9% since GPEI's foundation. An estimated 20 million people today are walking who would otherwise have been paralyzed by the disease, and more than 1.5 million people are alive, whose lives would otherwise have been lost. Now the task remains to tackle polio in its last few strongholds and get rid of the final 0.1% of polio cases including the two remaining endemic countries: Pakistan and Afghanistan. 1 World Health Organization, Global Polio Eradication Initiative, Technical Advisory Group urges strong action to eradicate polio in Afghanistan, February 26, 20252 Daly, C et al, Needle-free injectors for mass administration of fractional dose inactivated poliovirus vaccine (fIPV) in Karachi, Pakistan: A survey of caregiver and vaccinator acceptability, Vaccine, Volume 38 Issue 8, 18 February, 2020, Pages 1893-18983 Nouh, K et al, Use of a fractional dose of inactivated polio vaccine (fIPV) to increase IPV coverage among children under 5 years of age in Somalia, Springer Nature Volume 2 article number 16 (2024)4 Biya, O et al, Notes from the Field: House-to-House Campaign Administration of Inactivated Poliovirus Vaccine — Sokoto State, Nigeria, November 2022, CDC Morbidity and Mortality Weekly report, November 24, 2023 / 72(47);1290–12915 Global Polio Eradication Initiative, who we are: View source version on Contacts Nancy 1-888-900-4321 Option 3

WHO and UNICEF to Launch Polio Vaccination Campaign
WHO and UNICEF to Launch Polio Vaccination Campaign

Business Wire

time3 hours ago

  • Business Wire

WHO and UNICEF to Launch Polio Vaccination Campaign

GOLDEN, Colo.--(BUSINESS WIRE)-- PharmaJet ®, a company that strives to improve the performance and outcomes of injectables with its enabling needle-free injection technology, today announced that the WHO prequalified Tropis ID delivery system will be used to support a polio eradication campaign sponsored by the National Emergency Operation Center (NEOC) Afghanistan, UNICEF, WHO, and other GPEI partners starting in August 2025. Focused on the Eastern region of Afghanistan, the campaign will deploy Tropis ID to administer 1.3 million fractional doses of inactivated polio vaccine (fIPV) to children ages 5 and under in parallel to oral polio vaccine (OPV) administration as part of a WHO-recommended strategy to boost humoral and mucosal immunity. Poliovirus has been eliminated in most parts of the world due to widespread vaccination campaigns, but it continues to circulate in Afghanistan and Pakistan. In 2024, wild poliovirus type 1 (WPV1) transmission rose significantly in Afghanistan. The use of Tropis ID enables site-to-site immunization, a strategy where vaccination services are offered at multiple, convenient locations. This approach is expected to help increase immunization coverage, particularly in high-risk areas. The Technical Advisory Group (TAG) on polio eradication endorsed the Afghanistan program's 'Strategic Reset' to optimize site-to-site vaccination, while stressing the need for stronger leadership, community acceptance, and broad government engagement. Including Tropis ID fIPV in this immunization program supports Afghanistan's polio eradication goals to eliminate persistent virus lineages in the East, prevent new WPV1 cases in the East and South Regions, and prevent local transmission in other parts of the country. 1 'We are pleased to be partnering with UNICEF, WHO, and NEOC Afghanistan in their continued efforts to eradicate polio,' said Paul LaBarre, Senior Vice President Global Business Development, PharmaJet. 'We aim to achieve high impact in the fight against poliovirus, including increased coverage, decreased costs, and high acceptability 2 previously seen with Tropis ID delivered fIPV in Pakistan, 2 Somalia, 3 and Nigeria 4.' Refer to Instructions for Use to ensure safe injections and to review risks. About PharmaJet The PharmaJet mission is to improve the performance and outcomes of injectables with our enabling technology that better activates the immune system. We are committed to helping our partners realize their research and commercialization goals while making an impact on public health. PharmaJet Precision Delivery Systems™ can improve vaccine effectiveness, allow for a preferred patient and caregiver experience, and offer a proven path to commercialization. They are also safe, fast, and easy-to-use. The Stratis ® System has U.S. FDA 510(k) marketing clearance, CE Mark, and WHO PQS certification to deliver medications and vaccines either intramuscularly or subcutaneously. The Tropis ® System has CE Mark and WHO PQS certification for intradermal injections. They are both commercially available for global immunization programs. For more information or if you are interested in partnering with PharmaJet visit or contact PharmaJet here. Follow us on LinkedIn. About the NEOC Afghanistan NEOC Afghanistan is led by the Ministry of Public Health and the core members are WHO, UNICEF, BMGF, CDC, Rotary International, Core Group of Polio Project (CGPP), EPI manager and the National Polio Focal Point. About the Global Polio Eradication Initiative (GPEI) 5 The Global Polio Eradication Initiative is a public-private partnership led by national governments with six partners – the World Health Organization (WHO), Rotary International, the US Centers for Disease Control and Prevention (CDC), the United Nations Children's Fund (UNICEF), Gates Foundation and Gavi, the vaccine alliance. Its goal is to eradicate polio worldwide. Launched in 1988 after the World Health Assembly passed a resolution to eradicate polio, the Global Polio Eradication Initiative, along with its partners, has helped countries to make huge progress in protecting the global population from this debilitating disease. As a result, the global incidence of polio has decreased by 99.9% since GPEI's foundation. An estimated 20 million people today are walking who would otherwise have been paralyzed by the disease, and more than 1.5 million people are alive, whose lives would otherwise have been lost. Now the task remains to tackle polio in its last few strongholds and get rid of the final 0.1% of polio cases including the two remaining endemic countries: Pakistan and Afghanistan. 1 World Health Organization, Global Polio Eradication Initiative, Technical Advisory Group urges strong action to eradicate polio in Afghanistan, February 26, 2025 2 Daly, C et al, Needle-free injectors for mass administration of fractional dose inactivated poliovirus vaccine (fIPV) in Karachi, Pakistan: A survey of caregiver and vaccinator acceptability, Vaccine, Volume 38 Issue 8, 18 February, 2020, Pages 1893-1898 3 Nouh, K et al, Use of a fractional dose of inactivated polio vaccine (fIPV) to increase IPV coverage among children under 5 years of age in Somalia, Springer Nature Volume 2 article number 16 (2024) 4 Biya, O et al, Notes from the Field: House-to-House Campaign Administration of Inactivated Poliovirus Vaccine — Sokoto State, Nigeria, November 2022, CDC Morbidity and Mortality Weekly report, November 24, 2023 / 72(47);1290–1291 5 Global Polio Eradication Initiative, who we are:

Leading pediatrician group recommends COVID vaccine for infants, toddlers in contrast with RFK Jr.

time4 hours ago

Leading pediatrician group recommends COVID vaccine for infants, toddlers in contrast with RFK Jr.

The American Academy of Pediatrics (AAP) said on Tuesday that children ages 6 months to 23 months should receive a COVID-19 vaccine, in contrast with federal health officials. The recommendations are part of the AAP's annual childhood immunization schedule, which includes guidance for COVID, flu and RSV vaccines for those aged 18 and younger. The AAP has been releasing its own recommendations since the 1930s, but in a rare occurrence, the recommendations differ from those put out by the Centers for Disease Control and Prevention (CDC). The group also recommended Americans age 18 and under receive a COVID vaccine if they are at high risk of severe COVID, live in a long-term care facility or congregate setting, if they have never been vaccinated against COVID or if they live with someone at high risk for severe COVID. It comes after Health and Human Services secretary Robert F. Kennedy Jr. announced in late May that the CDC would no longer recommend the COVID vaccine for healthy children. The CDC, which is under Kennedy's purview, later updated the guidance to a " shared clinical decision making" model -- leaving the decision to vaccinate children to parents alongside advice from a doctor. The prior recommendations were that everyone aged 6 months and older get vaccinated against COVID with the most up-to-date shot. The contrasting vaccine recommendations highlight the growing rift between federal health officials and medical organizations on vaccine policy. "The academy has been making pediatric immunization recommendations since the 1930s, that has not changed," Dr. Susan J. Kressly, president of the AAP, told ABC News. "But what has changed is that this year, we're doing it in the environment of misinformation, which makes it more important than ever that we provide clear and confident guidance, because the majority of American families really depend on us for this guidance." Children between 6 months old and 23 months old are at the highest risk of severe COVID-19, and the vaccine can protect against serious illness, according to the AAP. "We know that this age group, that's the highest risk for severe disease," Kressly said. "And so we want to make sure that those children who are at highest risk and did not live through the pandemic -- they were not exposed to COVID viruses during the pandemic -- we want to make sure that they are protected as best as possible." Although medical organizations may differ in their vaccine recommendations, insurers often rely on the CDC's vaccine panel, known as the Advisory Committee on Immunization Practices (ACIP), recommendations to determine what they will and won't cover. If certain vaccines aren't recommended by the ACIP, it may lead to parents or guardians facing out-of-pocket costs if their children receive the shot. It could also mean the shots aren't covered by the Vaccines for Children (VFC) program, a federally funded program that provides no-cost vaccines to eligible children. "We need to work with our like-minded policy makers who understand the importance of keeping VFC vaccines available in every community for those children who depend on them," Kressly said. "At the same time, there are children in this country whose vaccines are paid for through commercial insurance, and we are having continuing conversations with major payers to make sure that those can be vaccines are available as well. Vaccination is part of high-quality preventive care, and we are confident that we can work with the payers to make sure that translated into policy."

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store